Filing Flows

Filing Flows › Voyager Therapeutics (VYGR) › Next earnings date

Voyager Therapeutics (VYGR) earnings: beat the estimate

Voyager Therapeutics (VYGR) reported on Nov 5, 2026 and beat the EPS estimate: −$0.40 against −$0.42 (+4.3%). Revenue was $4.0M for Q3 2026, -70% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+4.3% vs estimate
Beat rate100%

The last report

Voyager Therapeutics reported revenue of $4.0M for the third quarter 2026 (-70% Y/Y), net loss $24.7M. How it makes money → · Every quarter →

Voyager Therapeutics: EPS against the estimate, last 5 reportsVoyager Therapeutics: EPS against the estimate, last 5 reportsEstimateReported−$0.52−$0.47Nov 25−$0.51−$0.47Mar 26−$0.53−$0.47May 26−$0.51−$0.40Aug 26−$0.42−$0.40Nov 26
Latest (Nov 26): Estimate −$0.42, Reported −$0.40.

Voyager Therapeutics' latest quarter

Voyager Therapeutics, Q3 2026: revenue $4.0M (-70% year over year), operating margin -658.2%, net loss $24.7M, operating cash flow −$19.7M. The chart follows the revenue to costs, profit and cash.

Questions

Did Voyager Therapeutics beat earnings?

Voyager Therapeutics (VYGR) reported on Nov 5, 2026 and beat the EPS estimate: −$0.40 against −$0.42 (+4.3%).

When does VYGR report earnings?

The next date is not set yet.

Does Voyager Therapeutics usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.